ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
DemeRx Receives MHRA Approval for DMX-1002 Study for Opioid Use Disorder
March 17, 2021DemeRx IB, an atai Life Sciences (atai) platform company focused on developing ibogaine for the treatment of opioid use disorder (OUD), announced the company has approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to ... -
ATAI Announces Neuronasal Completes Pilot Study
November 05, 2020ATAI Life Sciences announced Neuronasal has completed its pilot study intended to show nose to brain delivery of N-acetylcysteine (NAC) in healthy volunteers. -
ATAI Launches Viridia Life Sciences to Develop Novel Formulations for Mental Health Conditions
July 29, 2020ATAI Life Sciences announced the launch of Viridia Life Sciences, a wholly-owned subsidiary developing novel formulations of N,N-Dimethyltryptamine (DMT) to treat a variety of mental health disorders.
Pharma Sources Insight January 2025
